report
US foreign aid cuts pressure health systems in emerging markets
US foreign aid cuts pressure health systems in emerging markets
At least 38% of USAID funds have been cut compared to FY 2024-25.
Medical writing market to be valued at $10.5b by 2032
Thanks to the growing demand for well-organised regulatory documentation.
Digital twins in healthcare market to hit $59.94b by 2030
Thanks to increased public and private investments.
Cell and gene therapy market to grow at 31.3% CAGR until 2030
Future treatments for DEB are expected to drive the sector’s growth.
What’s next for the APAC oxygen concentrator market?
Emerging countries like China, Japan, and India are major contributors to growth.
In vitro diagnostics to be valued at $141.9b by 2029
Point-of-care testing is gaining popularity over traditional hospital and clinic diagnostics.
Vietnam’s medical devices market set to grow despite tariff risks
Thanks to continuous public and private investment.
Laser technology market to double by 2032
The sector is expected to grow at a CAGR of 7.96%.
WHO agreement to strengthen global health preparedness : report
The agreement seeks to improve vaccine distribution and knowledge sharing.
Global biomarker market to reach $130.2b by 2029
Advancements in omics technologies are driving the sector’s growth.
Qatar's health expenditure to be valued at $11.5b by 2029
However, overall opportunities will be limited compared to other regional markets.
APAC’s price controls, tendering processes pose risks to pharma firms
Such practices could impact revenues and market access.
NGS data analysis market to hit $4.21b by 2032
Thanks to the growing need for personalised healthcare.
US tariffs to impact 78% of 510k-approved hospital supplies
It will directly impact 66% of supplies manufactured exclusively outside the country.
APAC’s HTA adoption to grow amidst infrastructure, talent challenges
Key markets include Indonesia, the Philippines, and Australia.
Oral proteins and peptides market to hit $24b by 2030
Its expansion is attributed to the prevalence of chronic diseases like diabetes.
Physicians divided over patient choice in biologics vs biosimilars
China’s physicians expressed the highest support amongst surveyed countries.
Most Read
1. NHG Health unveils Serangoon Polyclinic in Singapore 2. Chang Gung Hospital targets bigger Philippine patient base 3. Singapore–Malaysia medtech pilot seen luring more regional investment 4. Medical membranes market to be valued at $6.66b by 2030 5. Precious Medical Group launches $121.m cancer centre and hospital in JohorResource Center
Read Here
Advertise
Sign Up
Awards
Mar
26
Events
Event News
Healthcare Asia Awards 2025 Winner: Lee Ligang Zhang of iKang Healthcare Group
Lee Ligang Zhang of iKang Healthcare Group highlights how AI and precision diagnosis are transforming healthcare delivery today.
